Tyra Biosciences is a biotechnology company targeting acquired resistance in oncology with purpose-built drugs. A proprietary in-house discovery platform enables TYRA Biosciences to see the real-world interaction between drug and target in rapid, sequential, structural SNÅPshots. With each SNÅP, the company brings speed, clarity, and focus to structure-based drug design.